The phacoemulsification devices market will register a CAGR of close to 4% by 2023.
Glaucoma surgery combined with cataract surgery via phacoemulsification to gain traction in the market. Concomitant phacoemulsification and glaucoma surgery are together a viable treatment option for patients with both cataract and glaucoma. The minimally invasive glaucoma procedure combined with phacoemulsification results is faster visual rehabilitation and lowers the chances of intraocular pressure (IOP) spikes.
Market Overview
Technological advances in phacoemulsification
Many advances are taking place in cataract surgery. With the improvement in cataract surgeries, the results over the past few years has resulted in a positive impact. The most important change was marked by the introduction of phacoemulsification.
Lack of awareness and shortage of trained surgeons
There is a distinct lack of awareness about the importance of eye care across the globe, especially in emerging economies. Factors such as lack of skilled ophthalmologists and consumer knowledge about eye care limit the patient's accessibility to eye care in emerging markets.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Novartis and PhysIOL, the competitive environment is quite intense. Factors such as the glaucoma surgery combined with cataract surgery via phacoemulsification and the technological advances in phacoemulsification, will provide considerable growth opportunities to phacoemulsification devices manufactures.
Bausch Health, Carl Zeiss Meditec, Johnson & Johnson, NIDEK, Novartis, and PhysIOL are some of the major companies covered in this report.
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
Comparison by product
Phacoemulsification consumables
Phacoemulsification systems
Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
Geographic comparison
Key leading countries
Market opportunity
PART 09: DRIVERS AND CHALLENGES
Glaucoma surgery combined with cataract surgery via phacoemulsification
Increasing popularity of femtosecond laser as an alternative to phacoemulsification
Increasing medical tourism for low-cost cataract surgery
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Optical
Related Links:
Author: Copyright GlobeNewswire, Inc. 2016. All rights reserved. You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.